The final episode in our 3-part series covers the importance of innovation to develop and sustain long-term value in a partnership. Our experts discuss how innovation provides the opportunity to leverage each partners’ strength and can result in tangible cost savings and value creation.
Strategies for Accelerating Rare Disease Clinical Development
Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient…
PRA Successfully Delivers A Complex Phase I Psoriasis Study
Exceptional Support and Innovative Strategies Combat Study Challenges.
Long-term Benefits of Embedded Partnerships in Biometrics
This long-standing partner is a large, global, biopharmaceutical developer based in Japan; their focus is on oncology, neurology, infectious disease,…